Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn's disease: application of L émann Index.
Conclusion: Treatment with adalimumab halts the progression of bowel damage in CD while that with azathioprine does not.
PMID: 31692395 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
More News: Colonoscopy | Crohn's Disease | Gastroenterology | Humira | Inflammatory Bowel Disease | PET Scan | Study